Translational endpoints in patients with metastatic microsatellite-stable colorectal cancer (MSS-CRC) treated with durvalumab plus monalizumab (anti-NKG2A) Meeting Abstract
| Authors: | Diamond, J. R.; Standifer, N.; Ascierto, M. L.; Morehouse, C.; Ghadially, H.; Canales, J. R.; Rebelatto, M. C.; Naidoo, J.; Mazzarella, L.; Patel, S.; Oncala, M. J. F.; Gordoa, T. A.; Wang, D.; Song, X.; Jones, D. C.; Li, X.; Marshall, S.; Abdullah, S.; Jure-Kunkel, M.; Hellmann, M. D. |
| Abstract Title: | Translational endpoints in patients with metastatic microsatellite-stable colorectal cancer (MSS-CRC) treated with durvalumab plus monalizumab (anti-NKG2A) |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy288.067 |
| Language: | English |
| ACCESSION: | WOS:000459277302373 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy288.067 |
| Notes: | Meeting Abstract: 1194P -- Appears on page viii425 of the abstract book -- Source: Wos |
